Baidu
map

国家又双叒严打医药商业贿赂!药企数字化学术营销转型迫在眉睫!

2018-05-25 微天使 MedSci原创

国家又双叒严打医药商业贿赂!药企数字化学术营销转型迫在眉睫!

5月17日,国家市场监督管理总局发布《关于开展反不正当竞争执法重点行动的公告〔2018年第4号〕》。自2018年5月至10月,在全国范围内开展反不正当竞争执法重点行动。围绕网络交易、农村市场、医药、教育等行业和领域,集中整治社会关注度高、反映强烈的市场混淆、商业贿赂、虚假宣传以及涉网不正当竞争等突出问题,切实维护公平竞争市场秩序,维护经营者、消费者合法权益。严查什么?实际上,从两票制等政策实施以后,医药商业贿赂等问题变得更为隐蔽,这些小型所谓的伪CSO公司,规模小,十分分散,查处难度大,成本高。传统的带金销售模式,灰色部分主要是代理商进行兑付,代理商整体规模小,十分分散,查处难度大,成本高,是过过票的主力军。通过两票制,明确生产企业的主体责任,转型合规的学术营销。但是,很多企业并没有想着进行营销转型,也没有想着合规自己的销售行为,反而利用一些隐蔽的技巧,转嫁风险,分散资金等方式,躲蔽监管。最近两年全国各地成立数十万家伪CSO公司(过去代理商和销售代表转型),“解决”行业俗称最大的难题---过票。所谓伪CSO公司开个发票,让他们提供个所谓学术推广的证据链,厂家就把钱打给他,然后去兑付现金

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-27 仁医06
  6. [GetPortalCommentsPageByObjectIdResponse(id=1771781, encodeId=5c0f1e71781e1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Oct 27 13:16:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811232, encodeId=08011811232b5, content=<a href='/topic/show?id=e9be8e3123a' target=_blank style='color:#2F92EE;'>#药企数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87312, encryptionId=e9be8e3123a, topicName=药企数)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erCiat0j36p5MejdM9yCLtcVcY8WS5VIKuCMqXFNs56U6iacZib5CJvh6mVxGERicM6ZAkl91jMgpcDrw/132, createdBy=37622500012, createdName=ms2999106592497887, createdTime=Mon Jan 14 09:16:00 CST 2019, time=2019-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006626, encodeId=800d2006626e0, content=<a href='/topic/show?id=ff804006995' target=_blank style='color:#2F92EE;'>#商业贿赂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40069, encryptionId=ff804006995, topicName=商业贿赂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Sun Dec 30 18:16:00 CST 2018, time=2018-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363458, encodeId=a49b1363458aa, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409543, encodeId=fe00140954306, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535071, encodeId=628315350e11d, content=<a href='/topic/show?id=3df58e521e9' target=_blank style='color:#2F92EE;'>#药商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87521, encryptionId=3df58e521e9, topicName=药商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c72d12584423, createdName=soongzhihua, createdTime=Sun May 27 07:16:00 CST 2018, time=2018-05-27, status=1, ipAttribution=)]

相关资讯

啪啪啪到丁丁痛,是姿势不对,还是病了?

昆明新科泌尿专科医院是经卫生厅批准的西南首家集医疗、教学、科研、预防保健为一体的综合性昆明正规男科医院。医院秉承严谨求实的科学态度争创西南昆明男科医院三甲一流服务品牌。 地址:昆明市官渡区关上民航路460号 就诊时间:8:00-21:00 咨询电话:0871-68133120(无假日)昆明新科医院,看男科,我们是认真的。

昆明新科医院告诉你什么是急性宫颈炎

昆明新科医院表示,急性宫颈炎可由致病菌直接感染宫颈引起,也可继发于子宫内膜或荫道的炎症,如滴虫性荫道炎、霉菌性荫道炎,或许其它非特异性细菌感染。

昆明新科医院男科专家教你怎样增加男人勃起硬度

昆明新科泌尿专科医院是经卫生厅批准的西南首家集医疗、教学、科研、预防保健为一体的综合性昆明正规男科医院。医院秉承严谨求实的科学态度争创西南昆明男科医院三甲一流服务品牌。 地址:昆明市官渡区关上民航路460号 就诊时间:8:00-21:00 咨询电话:0871-68133120(无假日)昆明新科医院,看男科,我们是认真的。

男性朋友应该了解这些男科常识

昆明新科泌尿专科医院是经卫生厅批准的西南首家集医疗、教学、科研、预防保健为一体的综合性昆明正规男科医院。医院秉承严谨求实的科学态度争创西南昆明男科医院三甲一流服务品牌。 地址:昆明市官渡区关上民航路460号 就诊时间:8:00-21:00 咨询电话:0871-68133120(无假日)昆明新科医院,看男科,我们是认真的。

男性尿路感染的7大危害

昆明新科泌尿专科医院是经卫生厅批准的西南首家集医疗、教学、科研、预防保健为一体的综合性昆明正规男科医院。医院秉承严谨求实的科学态度争创西南昆明男科医院三甲一流服务品牌。 地址:昆明市官渡区关上民航路460号 就诊时间:8:00-21:00 咨询电话:0871-68133120(无假日)昆明新科医院,看男科,我们是认真的。

宫颈糜烂会导致不孕吗 昆明新科医院告诉你

昆明新科医院表示,宫颈溃烂是缓慢宫颈炎症的一种特别体现。多发生在分娩、流产、产褥感染或手术操作损害子宫颈之后,并常与阴道炎并存。

Baidu
map
Baidu
map
Baidu
map